2021323
PRHeartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan
202131
PRHeartseed named “Minister of Science and Technology Policy Award” at Japan Venture Awards 2021
2021128
OtherTaiji Edogawa was appointed as External Audit & Supervisory Board Member
